roche - Search News

Roche, obesity and Zealand

Roche secures Zealand obesity drug candidate for up to $5.3 billion

Roche has acquired rights to an obesity therapy by Denmark's Zealand Pharma in a collaboration deal worth up to $5.3 billion, as the Swiss drugmaker seeks to boost its prospects in the booming weight-loss market.

Quartz on MSN · 2d

Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today

Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market — which is projected to hit $105 billion by 2030, according to Morgan Stanley (MS) analysts.

AOL · 3d

Roche signs $5.3 billion deal with Danish obesity drugmaker, Novo stock slides 4%

Roche is increasing its investment into the obesity space with an up to $5.3 billion deal with Danish drugmaker Zealand Pharma , the companies announced Wednesday. The deal would

Investor's Business Daily on MSN · 3d

Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion

Roche and Zealand Pharma inked a $5.3 billion deal Wednesday to collaborate on a weight-loss drug in the amylin class.

Seeking Alpha · 3d

Roche-Zealand deal is the latest to boost obesity space

Viking Therapeutics (VKTX) stock gains as Roche (RHHBY) and Zealand Pharma's (ZLDPF) $5.3B deal for obesity drugs lifts weight loss drug stocks. Read more here.

acne, La Roche-Posay and Proactiv

CNN · 2d

Some La Roche-Posay, Proactiv and Walgreens acne treatments recalled due to benzene levels

U.S. health officials are asking retailers to pull a small number of acne creams from their store shelves after government testing found they contain slightly elevated levels of a chemical associated with cancer.

USA TODAY · 1d

Acne treatments from brands such as Walgreens, La Roche-Posay, Proactiv are being recalled

APP.com (Asbury Park, NJ) on M… · 2d

Why La Roche-Posay is pulling this acne treatment, and why you shouldn't use it

Parent company La Roche-Posay has pulled the Effaclar Duo Acne Spot Treatment from L'Oreal's lineup, due to a cancer-causing carcinogen contamination.

3don MSN

Roche takes big step in weight-loss field with $5.3 billion deal. Novo Nordisk shares fall.

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...

Fierce Pharma1d

Roche settles UPenn suit alleging patent infringement by Herceptin, 3 other breast cancer meds

Some three years after the University of Pennsylvania claimed four of Roche’s breast cancer meds infringed its intellectual ...

4don MSN

Roche, Zealand Pharma Strike $5.3 Billion Weight-Loss Therapy Deal

The companies agreed to share profits for the therapy equally in the U.S. and Europe, but Roche will have exclusive rights to ...

Fierce Biotech3d

Roche pads out obesity pipeline, paying Zealand $1.6B upfront to codevelop amylin asset

Roche is paying $1.65 billion in confirmed upfront fees to add to its burgeoning obesity pipelin | Roche is paying $1.65 ...

Roche Diagnostics supports UK eye cancer AI initiative

Roche Diagnostics is collaborating with the University of Liverpool to launch the Eye Cancer Artificial Intelligence Digital Bioresource (EYE-CAN-AID), a multi-modal image database that aims to boost ...

Analytics India Magazine1d

Inside Roche’s Leadership Formula for GCC Success in India

Roche’s work in India is powered by its digital centre of excellence, which Jamalamadaka mentioned “operates as an integral ...

ROCHE BOBOIS: MONTHLY NEWSLETTER - FEBRUARY 2025

Roche Bobois, the global leader in the high-end furniture market and the epitome of the French Art de Vivre, publishes its latest news every month. FEBRUARY 2025 LATEST NEWS PENINSULA PARIS ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Roche, obesity and Zealand

acne, La Roche-Posay and Proactiv

Related topics